HEALTHCARE LOCUMS PLC

(the "Company")

Statement re. Possible Offer

The Board of Healthcare Locums plc announces that it has received an approach which may or may not lead to an offer being made for the Company. A further announcement will be made as soon as possible.

Pursuant to Rule 2.10 of the City Code on Takeovers and Mergers, Healthcare Locums plc would like to confirm that, as at the close of business on 8 April 2010, the issued share capital consisted of 105,167,601 ordinary shares of 10p each, none of which are held in treasury. Accordingly, the number of shares carrying voting rights is 105,167,601. The ISIN reference number for these securities is GB00B0MD8242.

Contact information:

Healthcare Locums plc

Kate Bleasdale, Executive Vice Chairman

Tel: 0207 451 1451

Fairfax I.S. PLC

Ewan Leggat / Simon Bennett / Laura Littley

Tel: 0207 598 5368

Pelham Bell Pottinger

David Rydell / Emma Kent / Duncan Mayall

Tel: 020 7337 1500

Fairfax I.S. PLC which is authorised and regulated in the United Kingdom by the Financial Services Authority for investment business, is acting exclusively for Healthcare Locums plc and for no-one else in relation to the proposed Offer and is not acting for any other person in relation to the proposed Offer. Fairfax will not be responsible to anyone other than Healthcare Locums plc for providing the protections afforded to its clients or for providing advice in relation to the proposed Offer, the contents of this announcement or any offer or arrangement referred in this announcement.

Dealing disclosure requirements

Under the provisions of Rule 8.3 of the Code, if any person is, or becomes, "interested" (directly or indirectly) in one per cent or more of any class of "relevant securities" of Healthcare Locums plc, all "dealings" in any "relevant securities" of Healthcare Locums plc (including by means of an option in respect of, or a derivative referenced to, any such "relevant securities") must be publicly disclosed by no later than 3.30 p.m. (London time) on the business day following the date of the relevant transaction. This requirement will continue until the date on which the Offer becomes, or is declared, unconditional as to acceptance, lapses or is otherwise withdrawn or on which the "Offer Period" otherwise ends. If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire an "interest" in "relevant securities" of Healthcare Locums plc they will be deemed to be a single person for the purpose of Rule 8.3 of the Code.

Under the provisions of Rule 8.1 of the Code, all "dealings" in "relevant securities" of Healthcare Locums plc by Healthcare Locums plc or by any of their respective "associates" must be disclosed by no later than noon (London time) on the business day following the date of the relevant transaction.

A disclosure table, giving details of the companies in whose "relevant securities" "dealings" should be disclosed, and the number of such securities in issue, can be found on the Panel's website at www.thetakeoverpanel.org.uk.

"Interests in securities" arise, in summary, when a person has long economic exposure, whether conditional or absolute, to changes in the price of securities. In particular, a person will be treated as having an "interest" by virtue of the ownership or control of securities, or by virtue of any option in respect of, or derivative referenced to, securities.

Terms in quotation marks in the preceding paragraphs under the heading "Dealing disclosure requirements" are defined in the Code, which can also be found on the Panel's website. If you are in any doubt as to whether or not you are required to disclose a "dealing" under Rule 8 of the Code, you should consult the Panel.

This announcement is not intended to and does not constitute, or form any part of, an offer or an invitation to purchase or sell any securities or the solicitation of an offer to purchase any securities in any jurisdiction pursuant to the Offer or otherwise.